FindTrial
Sign In

Japan Azacitidine Reserch For CMML study

Japan Azacitidine Reserch For CMML study - JARC study

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000010846
Enrollment
40
Registered
2013-05-31
Start date
2012-11-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic myelomonocytic leukemia

Interventions

None listed

Sponsors

MDS study group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who received azacitidine between March 2011 and October 2012.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Overall survival, Response rates in IWG2006 response criteria.—

Countries

Japan

Contacts

Public ContactKensuke Usuki

NTT Medical Center Tokyo Department of Hematoglogy

kensuke.usuki@gmail.com03-3448-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026